Inflammation: the next target for secondary prevention in coronary artery disease

被引：5
作者：
Kazi, Samia [1 ,2 ]
Chong, James J. H. [2 ,3 ]
Chow, Clara K. [2 ,3 ]
机构：
[1] Univ Sydney, Westmead Appl Res Ctr, Sydney, NSW, Australia
[2] Westmead Hosp, Sydney, NSW, Australia
[3] Univ Sydney, Sydney, NSW, Australia
来源：
MEDICAL JOURNAL OF AUSTRALIA | 2024年 / 220卷 / 03期
基金：
澳大利亚国家健康与医学研究理事会; 英国医学研究理事会;
关键词：
Coronary artery disease; Risk factors; Anti-inflammatory agents; Inflammation; LOW-DOSE COLCHICINE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; RISK;
D O I：
10.5694/mja2.52209
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：115 / 120
页数：6
相关论文
共 50 条
[41]   Physical activity and sedentary behaviour in secondary prevention of coronary artery disease: A review [J].
Vasankari, Ville ;
Halonen, Jari ;
Vasankari, Tommi ;
Anttila, Vesa ;
Airaksinen, Juhani ;
Sievanen, Harri ;
Hartikainen, Juha .
AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2021, 5
[42]   The ADAPTABLE Trial and Aspirin Dosing in Secondary Prevention for Patients with Coronary Artery Disease [J].
Abigail Johnston ;
W. Schuyler Jones ;
Adrian F. Hernandez .
Current Cardiology Reports, 2016, 18
[43]   Personalized allocation of acetylsalicylic acid therapy for secondary prevention of coronary artery disease [J].
Hegde, Nischal N. ;
Mathew, Navin ;
Thachathodiyl, Rajesh ;
Menon, Jaideep C. .
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
[44]   Systemic inflammation is higher in peripheral artery disease than in stable coronary artery disease [J].
Rein, Philipp ;
Saely, Christoph H. ;
Silbernagel, Guenther ;
Vonbank, Alexander ;
Mathies, Rainer ;
Drexel, Heinz ;
Baumgartner, Iris .
ATHEROSCLEROSIS, 2015, 239 (02) :299-303
[45]   Low-Dose Colchicine for Secondary Prevention of Coronary Artery Disease JACC Review Topic of the Week [J].
Nelson, Kyle ;
Fuster, Valentin ;
Ridker, Paul M. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (07) :648-660
[46]   The Effects of Glucose Lowering Agents on the Secondary Prevention of Coronary Artery Disease in Patients with Type 2 Diabetes [J].
Jung, Inha ;
Kwon, Hyemi ;
Park, Se Eun ;
Han, Kyung-Do ;
Park, Yong-Gyu ;
Rhee, Eun-Jung ;
Lee, Won-Young .
ENDOCRINOLOGY AND METABOLISM, 2021, 36 (05) :977-987
[47]   Evaluation of Secondary Prevention Knowledge in Patients with Coronary Artery Disease [J].
Balint, Gabriel ;
Slezakova, Zuzana .
MEDICINA-LITHUANIA, 2025, 61 (04)
[48]   Evaluation of a Telemedicine Service for the Secondary Prevention of Coronary Artery Disease [J].
Blasco, Ana ;
Carmona, Montserrat ;
Fernandez-Lozano, Ignacio ;
Salvador, Carlos H. ;
Pascual, Mario ;
Sagredo, Pilar G. ;
Somolinos, Roberto ;
Munoz, Adolfo ;
Garcia-Lopez, Fernando ;
Escudier, Juan M. ;
Mingo, Susana ;
Toquero, Jorge ;
Monivas, Vanessa ;
Gonzalez, Miguel A. ;
Fragua, Juan A. ;
Lopez-Rodriguez, Fernando ;
Monteagudo, Jose L. ;
Alonso-Pulpon, Luis .
JOURNAL OF CARDIOPULMONARY REHABILITATION AND PREVENTION, 2012, 32 (01) :25-31
[49]   A New Perspective for Chinese Medicine Intervention for Coronary Artery Disease: Targeting Inflammation [J].
Li Si-ming ;
Li Jin-gen ;
Xu Hao .
CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2019, 25 (01) :3-8
[50]   The hidden risk: Incorporating inflammation and HIV serostatus into coronary artery disease screening [J].
Payne, Gregory A. ;
Overton, Edgar Turner .
JOURNAL OF NUCLEAR CARDIOLOGY, 2018, 25 (03) :884-886
12345